Improving Psychological Health Outcomes in Children with Atopic Dermatitis

References

• Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483–1494. doi:10.1056/NEJMra074081
   PubMed Web of Science ®Google Scholar
• Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl 1):8–16. doi:10.1159/000370220
   PubMed Web of Science ®Google Scholar
• Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI; ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251–1258.e23. doi:10.1016/j.jaci.2009.10.009
   PubMed Web of Science ®Google Scholar
• Lifschitz C. The Impact of Atopic Dermatitis on Quality of Life. Ann Nutr Metab. 2015;66(Suppl. 1):34–40. doi:10.1159/000370226
   PubMed Web of Science ®Google Scholar
• Xie QW, Dai X, Tang X, Chan CHY, Chan CLW. Risk of mental disorders in children and adolescents with atopic dermatitis: a systematic review and meta-analysis. Front Psychol. 2019;10:1773. doi:10.3389/fpsyg.2019.01773
   PubMed Web of Science ®Google Scholar
• Loo EXL, Ooi DSQ, Ong M, et al. Associations between eczema and attention deficit hyperactivity disorder symptoms in children. Front Pediatr. 2022;10:837741. doi:10.3389/fped.2022.837741
   PubMed Web of Science ®Google Scholar
• Chow MYK, Morrow AM, Cooper Robbins SC, Leask J. Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review. Qual Life Res. 2013;22(8):2183–2200. doi:10.1007/s11136-012-0343-z
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee GN, Lee JH, Han JH, Han K, Park YM. Psychological stress in parents of children with atopic dermatitis: a cross-sectional study from the Korea National Health and Nutrition Examination Survey. Acta Derm Venereol. 2023;103:2242. doi:10.2340/actadv.v103.2242
   PubMed Web of Science ®Google Scholar
• Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol. 2006;154(3):514–518. doi:10.1111/j.1365-2133.2005.07082.x
   PubMed Web of Science ®Google Scholar
• Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. The impact of pediatric atopic dermatitis on families: a review. Pediatr Dermatol. 2019;36(1):66–71. doi:10.1111/pde.13727
   PubMed Web of Science ®Google Scholar
• Davari DR, Nieman EL, McShane DB, Morrell DS. Current perspectives on the management of infantile atopic dermatitis. J Asthma Allergy. 2020;13:563–573. doi:10.2147/JAA.S246175
   PubMed Web of Science ®Google Scholar
• Ersser SJ, Cowdell F, Latter S, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2014;2014(1):CD004054. doi:10.1002/14651858.CD004054.pub3
   PubMedGoogle Scholar
• Kwan B, Rickwood DJ. A systematic review of mental health outcome measures for young people aged 12 to 25 years. BMC Psychiatry. 2015;15:279. doi:10.1186/s12888-015-0664-x
   PubMed Web of Science ®Google Scholar
• Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–949. doi:10.1111/j.1365-2133.1995.tb16953.x
   PubMed Web of Science ®Google Scholar
• Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants’ Dermatitis Quality of Life Index. Br J Dermatol. 2001;144(1):104–110. doi:10.1046/j.1365-2133.2001.03960.x
   PubMed Web of Science ®Google Scholar
• Ali FM, Johns N, Salek S, Finlay AY. Correlating the Dermatology Life Quality Index with psychiatric measures: a systematic review. Clin Dermatol. 2018;36(6):691–697. doi:10.1016/j.clindermatol.2018.08.014
   PubMed Web of Science ®Google Scholar
• Phillips B, Ball C, Sackett D. Oxford centre for evidence-based medicine: levels of evidence; 2009 [ cited July 31, 2023]. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed October 4, 2023.
   Google Scholar
• Na CH, Chung J, Simpson EL. Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families. Children. 2019;6(12):133. doi:10.3390/children6120133
   PubMedGoogle Scholar
• de Graaf M, Janmohamed SR, Schuttelaar MLA, et al. Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe. J Eur Acad Dermatol Venereol. 2022;36(11):2153–2165. doi:10.1111/jdv.18410
   PubMed Web of Science ®Google Scholar
• van Halewijn KF, Lahnstein T, Bohnen AM, et al. Recommendations for emollients, bathing and topical corticosteroids for the treatment of atopic dermatitis: a systematic review of guidelines. Eur J Dermatol. 2022;32(1):113–123.
   PubMed Web of Science ®Google Scholar
• Kritsanaviparkporn C, Sangaphunchai P, Treesirichod A. Efficacy of moisturizers in paediatric atopic dermatitis: a systematic review and meta-analysis of randomised controlled trials. IJDVL. 2021;88(1):22–31. doi:10.25259/IJDVL_1384_20
   Google Scholar
• Ridd MJ, Santer M, MacNeill SJ, et al. Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, Phase 4, superiority trial. Lancet Child Adolescent Health. 2022;6(8):522–532. doi:10.1016/S2352-4642(22)00146-8
   PubMedGoogle Scholar
• Liang J, Hu F, Tang H, et al. Systematic review and network meta-analysis of different types of emollient for the prevention of atopic dermatitis in infants. J Eur Acad Dermatol Venereol. 2023;37(3):501–510. doi:10.1111/jdv.18688
   PubMed Web of Science ®Google Scholar
• Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016;16(1):75. doi:10.1186/s12887-016-0607-9
   PubMed Web of Science ®Google Scholar
• Sokolova A, Smith SD. Factors contributing to poor treatment outcomes in childhood atopic dermatitis. Australas J Dermatol. 2015;56(4):252–257. doi:10.1111/ajd.12331
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32(6):850–878. doi:10.1111/jdv.14888
   PubMed Web of Science ®Google Scholar
• Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019;80(2):411–416.e4. doi:10.1016/j.jaad.2018.09.053
   PubMed Web of Science ®Google Scholar
• Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21(5):606–619. doi:10.1111/j.1468-3083.2006.02023.x
   PubMed Web of Science ®Google Scholar
• von Rueden U, Bunikowski R, Braeutigam M, Staab D. Cyclosporin A treatment of children with severe atopic dermatitis improves quality of life of their mothers. Dermatol Psychosom. 2002;3(1):14–18. doi:10.1159/000051358
   Google Scholar
• Downing HJ, Pirmohamed M, Beresford MW, Smyth RL. Paediatric use of mycophenolate mofetil. Br J Clin Pharmacol. 2013;75(1):45–59. doi:10.1111/j.1365-2125.2012.04305.x
   PubMed Web of Science ®Google Scholar
• Dvorakova V, O’Regan GM, Irvine AD. Methotrexate for severe childhood atopic dermatitis: clinical experience in a tertiary center. Pediatr Dermatol. 2017;34(5):528–534. doi:10.1111/pde.13209
   PubMed Web of Science ®Google Scholar
• Anderson K, Putterman E, Rogers RS, Patel D, Treat JR, Castelo-Soccio L. Treatment of severe pediatric atopic dermatitis with methotrexate: a retrospective review. Pediatr Dermatol. 2019;36(3):298–302. doi:10.1111/pde.13781
   PubMed Web of Science ®Google Scholar
• Fuggle NR, Bragoli W, Mahto A, Glover M, Martinez AE, Kinsler VA. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. J Am Acad Dermatol. 2015;72(1):108–114. doi:10.1016/j.jaad.2014.08.048
   PubMed Web of Science ®Google Scholar
• Cusack C, Connolly C, Watson R, Irvine A. Experience with azathioprine in a childhood population with severe atopic eczema over an eight year period. Arch Dis Child. 2008;93(Suppl 2):174–ps174. doi:10.1136/adc.2007.127266
   PubMedGoogle Scholar
• Caufield M, Tom WL. Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring. J Am Acad Dermatol. 2013;68(1):29–35. doi:10.1016/j.jaad.2012.07.001
   PubMed Web of Science ®Google Scholar
• Paller AS, Siegfried EC, Thaçi D, et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled Phase 3 trial. J Am Acad Dermatol. 2020;83(5):1282–1293. doi:10.1016/j.jaad.2020.06.054
   PubMed Web of Science ®Google Scholar
• Johnson H, Yu J. Current and emerging therapies in pediatric atopic dermatitis. Dermatol Ther. 2022;12(12):2691–2703. doi:10.1007/s13555-022-00829-4
   Web of Science ®Google Scholar
• Guttman-Yassky E, Teixeira HD, Simpson EL, et al. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. Lancet. 2021;397(10290):2151–2168. doi:10.1016/S0140-6736(21)00588-2
   PubMed Web of Science ®Google Scholar
• Papp K, Szepietowski JC, Kircik L, et al. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies. J Am Acad Dermatol. 2021;85(4):863–872. doi:10.1016/j.jaad.2021.04.085
   PubMed Web of Science ®Google Scholar
• Sidbury R, Davis DM, Cohen DE, et al. GUIDELINES OF CARE FOR THE MANAGEMENT OF ATOPIC DERMATITIS. J Am Acad Dermatol. 2014;71(2):327–349. doi:10.1016/j.jaad.2014.03.030
   PubMed Web of Science ®Google Scholar
• Clayton TH, Clark SM, Turner D, Goulden V. The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy. Clin Exp Dermatol. 2007;32(1):28–33. doi:10.1111/j.1365-2230.2006.02292.x
   PubMed Web of Science ®Google Scholar
• Jekler J, Larkö O. UVB phototherapy of atopic dermatitis. Br J Dermatol. 1988;119(6):697–705. doi:10.1111/j.1365-2133.1988.tb03490.x
   PubMed Web of Science ®Google Scholar
• Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol. 1996;13(5):406–409. doi:10.1111/j.1525-1470.1996.tb00711.x
   PubMed Web of Science ®Google Scholar
• Uetsu N, Horio T. Treatment of persistent severe atopic dermatitis in 113 Japanese patients with oral psoralen photo-chemotherapy. J Dermatol. 2003;30(6):450–457. doi:10.1111/j.1346-8138.2003.tb00415.x
   PubMed Web of Science ®Google Scholar
• Musters AH, Mashayekhi S, Harvey J, et al. Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021;10(10). doi:10.1002/14651858.CD013870.pub2
   PubMedGoogle Scholar
• Katayama I, Aihara M, Ohya Y, et al. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017;66(2):230–247. doi:10.1016/j.alit.2016.12.003
   PubMed Web of Science ®Google Scholar
• Zhao M, Liang Y, Shen C, Wang Y, Ma L, Ma X. Patient education programs in pediatric atopic dermatitis: a systematic review of randomized controlled trials and meta-analysis. Dermatol Ther. 2020;10(3):449–464. doi:10.1007/s13555-020-00365-z
   Web of Science ®Google Scholar
• de Bes J, Legierse CM, Prinsen CAC, de Korte J. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol. 2011;91(1):12–17. doi:10.2340/00015555-1022
   PubMed Web of Science ®Google Scholar
• Schuttelaar MLA, Vermeulen KM, Drukker N, Coenraads PJ. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol. 2010;162(1):162–170. doi:10.1111/j.1365-2133.2009.09502.x
   PubMed Web of Science ®Google Scholar
• Moore E, Williams A, Manias E, Varigos G. Nurse-led clinics reduce severity of childhood atopic eczema: a review of the literature. Br J Dermatol. 2006;155(6):1242–1248. doi:10.1111/j.1365-2133.2006.07534.x
   PubMed Web of Science ®Google Scholar
• Santer M, Muller I, Becque T, et al. Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials. BMJ. 2022;379:e072007. doi:10.1136/bmj-2022-072007
   PubMedGoogle Scholar
• Rork JF, Sheehan WJ, Gaffin JM, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–392. doi:10.1001/archdermatol.2011.2267
   PubMedGoogle Scholar
• Gilliam AE, Madden N, Sendowski M, Mioduszewski M, Duderstadt KG. Use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD): a randomized controlled trial. J Am Acad Dermatol. 2016;74(2):375–377.e1–e3. doi:10.1016/j.jaad.2015.08.067
   Web of Science ®Google Scholar
• Bakaa L, Pernica JM, Couban RJ, et al. Bleach baths for atopic dermatitis: a systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE. Ann Allergy Asthma Immunol. 2022;128(6):660–668.e9. doi:10.1016/j.anai.2022.03.024
   PubMed Web of Science ®Google Scholar
• Hon KL, Tsang YCK, Lee VWY, et al. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: a randomized, placebo-controlled cross-over trial. J Dermatolog Treat. 2016;27(2):156–162. doi:10.3109/09546634.2015.1067669
   PubMed Web of Science ®Google Scholar
• Sokel B, Christie D, Kent A, et al. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypnos. 1993. Available from: https://www.semanticscholar.org/paper/A-comparison-of-hypnotherapy-and-biofeedback-in-The-Sokel-Christie/ec29e10b32a7f5eb252fc0e6160f43687f04c67a.
   Google Scholar
• Sears AV, Ali R, O’Connor J, Baron S. Establishing and developing a paediatric psychodermatology service and our experience of a new paediatric psychodermatology clinic during the Covid 19 pandemic. Skin Health Dis. 2022;2(4):e151. doi:10.1002/ski2.151
   PubMedGoogle Scholar
• Heapy C, Norman P, Emerson LM, Murphy R, Bögels S, Thompson AR. Mindful parenting intervention for parents of children with skin conditions: a single group experimental cases series. Behav Cogn Psychother. 2022;50(5):462–480. doi:10.1017/S1352465822000170
   PubMed Web of Science ®Google Scholar
• Kita H. How are airborne allergens remembered by the immune system? J Allergy Clin Immunol. 2022;149(6):1940–1942. doi:10.1016/j.jaci.2022.02.014
   PubMed Web of Science ®Google Scholar
• Yepes-Nuñez JJ, Guyatt GH, Gómez-Escobar LG, et al. Allergen immunotherapy for atopic dermatitis: systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. 2023;151(1):147–158. doi:10.1016/j.jaci.2022.09.020
   PubMed Web of Science ®Google Scholar
• Song K, Kim M, Park M, Rhee E, Yu J. The Therapeutic and Preventive Effect of Sublingual Immunotherapy in Mite-Sensitized Children with Atopic Dermatitis: A Randomized, Open, Parallel-Group Study. 111 River St, Hoboken 07030-5774, NJ USA: Wiley; 2020:47–48.
   Google Scholar
• Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2007;120(1):164–170. doi:10.1016/j.jaci.2007.04.008
   PubMed Web of Science ®Google Scholar
• Abdallah B, Badr LK, Hawwari M. The efficacy of massage on short and long term outcomes in preterm infants. Infant Behav Dev. 2013;36(4):662–669. doi:10.1016/j.infbeh.2013.06.009
   PubMed Web of Science ®Google Scholar
• Lin L, Yu L, Zhang S, Liu J, Xiong Y. The positive effect of mother-performed infant massage on infantile eczema and maternal mental state: a randomized controlled trial. Front Public Health. 2022;10:1068043. doi:10.3389/fpubh.2022.1068043
   PubMedGoogle Scholar